This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Introduction/New Treatment Options to Improve Clinical Outcomes

Joseph P. McEvoy, M.D.

Published: January 1, 1998

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The l990s have already proved to be an exciting time in clinical psychopharmacology.New antipsychotic agents that offer improved therapeutic efficacy and better tolerability for our patients have become available.These agents initially received approval for use in one or two specific disordersbased on large, well-designed clinical trials in carefully selected, medically healthyadult populations.1-6


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...